Literature DB >> 17616987

Bronchioloalveolar carcinoma: a review of current concepts and evolving issues.

Samuel A Yousem1, Mary Beth Beasley.   

Abstract

CONTEXT: The concept of bronchioloalveolar carcinoma underwent considerable refinement between the publications of the 1981 and 1999 World Health Organization classifications of lung tumors. Both pathologic and clinical aspects of this carcinoma are the subject of considerable interest.
OBJECTIVE: To review and summarize the evolution of the current concept of bronchioloalveolar carcinoma and evolving issues that are under further investigation. DATA SOURCES: Pertinent peer-reviewed literature emphasizing historical classification and evolution as well as current and evolving concepts.
CONCLUSIONS: Small, solitary, nonmucinous bronchioloalveolar carcinomas are associated with a markedly better prognosis compared with conventional invasive adenocarcinomas. Such tumors may be cured by surgical resection and may be more responsive to epidermal growth factor receptor-targeted therapy. The prognosis and staging of multifocal disease remain unresolved, as does the question of whether a small amount of invasion adversely affects prognosis. Mucinous bronchioloalveolar carcinoma appears to be a markedly different entity than the nonmucinous subtype.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17616987     DOI: 10.5858/2007-131-1027-BCAROC

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  7 in total

Review 1.  The 2011 IASLC/ATS/ERS pulmonary adenocarcinoma classification: a landmark in personalized medicine for lung cancer management.

Authors:  Yong Tang; Zhe He; Qihang Zhu; Guibin Qiao
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

Review 2.  Can CT Screening Give Rise to a Beneficial Stage Shift in Lung Cancer Patients? Systematic Review and Meta-Analysis.

Authors:  Zixing Wang; Yaoda Hu; Yuyan Wang; Wei Han; Lei Wang; Fang Xue; Xin Sui; Wei Song; Ruihong Shi; Jingmei Jiang
Journal:  PLoS One       Date:  2016-10-13       Impact factor: 3.240

Review 3.  Upcoming Revolutionary Paths in Preclinical Modeling of Pancreatic Adenocarcinoma.

Authors:  Mirna Swayden; Philippe Soubeyran; Juan Iovanna
Journal:  Front Oncol       Date:  2020-01-22       Impact factor: 6.244

4.  Diagnosis-to-surgery interval and survival for different histologies of stage I-IIA lung cancer.

Authors:  Lu Zhang; Mei-Chin Hsieh; Lior Rennert; Paige Neroda; Xiao-Cheng Wu; Chindo Hicks; Jiande Wu; Ronald Gimbel
Journal:  Transl Lung Cancer Res       Date:  2021-07

5.  Clinical importance of [18F]fluorodeoxyglucose positron emission tomography/computed tomography in the management of patients with bronchoalveolar carcinoma: Role in the detection of recurrence.

Authors:  Evangelia Skoura; Ioannis E Datseris; Dimitrios Exarhos; Sophia Chatziioannou; Georgios Oikonomopoulos; Alexandros Samartzis; Chariklia Giannopoulou; Konstantinos N Syrigos
Journal:  Oncol Lett       Date:  2013-03-14       Impact factor: 2.967

Review 6.  Understanding Idiopathic Interstitial Pneumonia: A Gene-Based Review of Stressed Lungs.

Authors:  Coline H M van Moorsel; Thijs W Hoffman; Aernoud A van Batenburg; Dymph Klay; Joanne J van der Vis; Jan C Grutters
Journal:  Biomed Res Int       Date:  2015-10-11       Impact factor: 3.411

7.  Spread through air spaces (STAS) in invasive mucinous adenocarcinoma of the lung: Incidence, prognostic impact, and prediction based on clinicoradiologic factors.

Authors:  Min A Lee; Jun Kang; Ho Yun Lee; Wooil Kim; Insuk Shon; Na Young Hwang; Hong Kwan Kim; Yong Soo Choi; Jhingook Kim; Jae Ill Zo; Young Mog Shim
Journal:  Thorac Cancer       Date:  2020-09-25       Impact factor: 3.500

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.